Ms Munmun, a 43-year-old female from Durgapur, West Bengal, presented with abdominal distension. She had a history of ...

Ms Munmun, a 43-year-old female from Durgapur, West Bengal, presented with abdominal distension. She had a history of unilateral salpingo-oophorectomy 25 years prior. She was diagnosed with ...

Jenna Scott remembers the joy of being pregnant with her first and only child. She also remembers the immense abdominal pain. During her pregnancy, she let her doctors know about the persistent ...

Colorectal cancer has become the leading cause of death due to cancer for people under 50 in the United States. In the early 1990s, the disease ranked fifth. A new report from the American Cancer ...

Mortality from the deadliest cancers has decreased among people younger than 50 over the last three decades in the U.S., with the exception of colorectal cancer. Colorectal cancer, the fifth most ...

Guzmán, P. and Halpern, M. (2026) Effects of Treatment Delays on Colorectal Cancer Survival. Journal of Cancer Therapy, 17, ...

Colorectal cancer is now the leading cause of cancer-related death among people under 50 in the United States, according to new evidence from the American Cancer Society. The evidence, published ...

Drinking alcohol is linked to higher chances of colorectal cancer − but just how many drinks increase your risk? New research, published Jan. 26 in the American Cancer Society's peer-reviewed journal ...

Colorectal cancer was the leading cause of cancer death among young people in 2023, according to the American Cancer Society. Even as fewer young people have been dying from cancer in the last three ...

Cancer risk in solid-organ transplant patients may also be influenced by the presence of hereditary cancer susceptibility (HCS), typically due to a germline loss-of-function variant in a tumor ...

Colorectal cancer is now the leading cause of cancer deaths among people younger than 50 in the United States, according to a study published Thursday in the Journal of the American Medical ...

Guardant Health snagged the FDA green light to use its Guardant360 CDx colon cancer diagnostic along with Pfizer’s colon and skin cancer drug Braftovi in combination with cetuximab and chemotherapy.